chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning her daughter who was vaccinated with a dose of MMR II at 12 months of age. Subsequently, the results of a titer drawn in Dec 2001 did not show immunity to mumps. Unspecified medical attention was sought. Additional info has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Cellulitis, Discomfort, Erythema, Oedema
Clinical narrative: Information has been received from a medical assistant concerning a 5 year old female with no known allergies and no prior medical history who on 8/20/02 was vaccinated in the left arm with a dose of MMR II (641017/1097L). Concomitant vaccination included poliovirus vaccine inactivated in the left arm, DTaP in the right arm and hep A vaccine in the right arm. Later in the day on 8/20/02, the pt was seen in the physician's office for cellulitis, in which redness and swelling extended from shoulder to elbow and Keflex was prescribed. The pt was afebrile. On 8/22/02, the pt was taken to the ER for continued discomfort. On 8/23/02, the pt was seen again in the physician's office and the redness was reported as "down" and she was finishing the Keflex. The reported expressed a concern regarding to the lot number. The records of testing prior to release of this lot have been checked by GMP compliance and found to be satisfactory. The lot complies with the standards of the center for biologics evaluation and research and was released. It was also reported that another child (WAES0208USA04192) received a dose of MMR II (641017/1097L) and had a local reaction. In addition, three other children received a dose of MMR II (641017/1097L) and none had a reaction. Additional info has been requested.
Age: 50.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Myalgia
Clinical narrative: Information has been received from a physician concerning a 50 year old female who was vaccinated with MMR II prior to medical school. Subsequently the pt experienced arthralgias and myalgia. Unspecified medical attention was sought. Additional info has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Discomfort, Medication error, Pruritus, Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old female who on 8/27/02 was vaccinated with a second dose of MMR II (640635/1480L). Concomitant vaccination in the left arm included a dose of IPOL and a dose of DTaP. The pt "pulled away" during administration of the MMR II and the dose was inadvertently injected intradermally. A wheal formed in the skin. Itching and discomfort were also reported and there were no other complaints. Unspecified medical attention was sought and Benadryl cream was prescribed. Additional info has been requested.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning a 21 year old female with no known drug allergies, who on 11/8/82 and 12/8/92 was vaccinated with a first and second dose of MMR II. On 8/9/02 the pt had a "titer" drawn which showed that she "failed to seroconvert to mumps and measles." Unspecified medical attention was sought. Additional info has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Anxiety, Convulsion, Eye movement disorder, Somnolence
Clinical narrative: Information has been received from a physician concerning a 4 year old female with no past medical history and no known drug allergies who on 8/29/02 was vaccinated with a second dose of MMR (second generation) (lot # 638598/1305L and diluent lot # 636173/1305L). There was no illness at the time of the vaccination and no concomitant medication. Within one minute of receiving the vaccine, the patient experienced a seizure with eyes rolled back and body stiffening, lasting less than one minute. No treatment medication was required. Following the seizure the patient was sleepy and returned to her home. She was scheduled for an electroencephalogram on 8/30/02. It was noted that the patient had no history of seizure activity and that there were no adverse symptoms after the first dose of MMR (second generation) given a few years ago. The physician was unsure if the patient might have become anxious before the injection and that had precipitated the event. Upon internal review, seizure was determined to be an other important medical event (OMIC). Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a medical assistant concerning a 14 month old female who on approximately 2/5/99, was vaccinated with a dose of MMR II. The pt "broke out in hives after the dose had been given." Follow-up info received from a registered nurse indicated that twenty-four hours after vaccination, on 2/6/02, the pt developed hives. The pt recovered on an unknown date. Additional info is not expected.
Age: 1.25
Sex: M
Vaccine: DTAP, MMR
Symptoms: Otitis media, Pruritus, Pyrexia, Rash papular
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old white male child with no allergies, who on 8/22/02 was vaccinated SC with a first 0.5ml dose of MMR (second generation) (lot # 642695/0490M). Concomitant vaccination on 8/22/02 included an IM 0.5ml dose of aluminum, potassium (+) diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (TRIPEDIA) (lot C0813AA). The patient was well at the time of vaccination, and although he had no previous exposure to this or a related drug, he had previously tolerated all other immunizations without any adverse experiences. On 8/31/02 the patient developed a fever. On 9/2/02, the patient's mother called the physician's office to report that the child had a fever of 105.7F with a rash that consisted of pink bumps that blanched and itched located on his neck, back, and chest. On 9/3/02, the child was seen in the physician's office and diagnosed with a red papular rash on his neck, chest, arms, back, and legs. At this time, the physician also diagnosed left otitis media and fluid in the right ear. This was considered to be an incidental finding. The child was given ibuprofen for his fever and the physician also prescribed amoxicillin trihydrate (+) clavulanate potassium and hydroxine HCL for the itching. The child was referred to an ENT for the otitis media. It was also reported that the patient's sibling had fever, which started 9/2/02, and symptoms of Coxsackie virus on 9/3/02. on 9/24/02, the nurse reported that the patient had since recovered with his fever lasting 48 hours and the rash lasting gone week. The patient's fever was considered to be an other important medical event. No further information is expected.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site rash
Clinical narrative: Information has been received from a nurse practitioner concerning a 4 year old male with no prior medical history and no known allergies who on 8/28/02 was vaccinated with a dose of MMR II (641623/0125M). Concomitant vaccination included varicella virus vaccine live (639132/0502L), IPOL, and DTaP. On 8/30/02 the pt presented to the physician's office with "lesions of 4cm x 2.5cm" on the upper right deltoid around the injection site. It was not documented which vaccine had been administered at this site. The pt was diagnosed with impetigo and oral antibiotics were prescribed. It was reported on 9/5/02 that the pt will be seen in the office again in 10 days. Additional info has been requested.
Age: 39.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a 39 year old female who in November 2000 and February 2001, was vaccinated with a first and second dose of MMR II. The results of a "titer" done in March 2002,showed that the pt is "still non-immune to mumps." Unspecified medical attention was sought. Additional info has been requested.
Sex: U
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a physician concerning a pt (age and gender not given) with an egg allergy who was vaccinated on an unknown date with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not given). Subsequently the pt experienced an adverse event that was not otherwise specified. It was unknown if the pt sought medical attention. Additional info has been requested.
Sex: U
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Information has been received from a physician concerning a patient who on 09/06/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Concomitant medications were unspecified.  On approximately 09/11/2002, the patient developed an atypical case of measles.  The patient sought unspecified medical attention.  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a registered nurse, at a public health center, concerning a female who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, the patient had a negative measles titer.  The reporter stated she had no further information, as the patient was at a local physician's office.  It was unknown if medical attention was sought.  Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: DTAP, HEP, MMR
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Information has been received from a licensed practical nurse concerning an 11 year old male patient with an allergy to egg whites, no known drug allergies and history of asthma who on 09/09/2002 at 10:00 was vaccinated in the right hip with an intramuscular injection of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(642439/0234M), which had been reconstituted with a dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (Infanrix)(Lot # provided: U0306).  Subsequently the patient developed redness and slight swelling at the injection site.  Follow-up information received from a health care provider indicated that on 09/09/2002 at 10:00, the patient also received a dose of hepatitis B virus vaccine rHBsAg (yeast)(Lot # 641450/1498L) given intramuscular in the left arm.  In the follow-up information received it is unknown whether the patient has had adverse experiences with prior vaccination.  It was noted that no laboratory tests were performed.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old white female student with no known drug allergies, who on 09/09/2002 at 15:00 was vaccinated intramuscularly in the left hip with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642439/0234M) that had been "reconstituted" with diphtheria toxoid/pertussis vaccine/teta (Lot # V0306AC).  There was no illness at the time of vaccination.  At 15:00 on 09/09/2002, the patient developed redness and slight swelling at the injection site.  The patient sought unspecified medical attention.  Subsequently, the patient recovered.  Additional information is not expected.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a pharmacist concerning an approximately 25 year old female patient, who on 07/23/2000 was vaccinated with a third dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently the patient recently tested negative.  It was reported the patient had received two previous doses of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation), the dates are unknown.  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Information has been received from a physician concerning a female patient who on 09/13/2002 was vaccinated subcutaneously in the left thigh with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 0381M, not a valid Lot # for the product).  Subsequently the injection site developed a small area of redness and was tender to touch.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician concerning a 23-year-old female patient with no known drug allergies, a history of Spherocytosis, and splenectomy for Spherocytosis at age 19 years.  On 07/14/1980 and 01/10/1995, she was vaccinated with a dose, measles virus vaccine live(+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medication.  Subsequently it is reported the patient's current titer is negative for measles and mumps.  Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Convulsion
Clinical narrative: Information has been received from a registered nurse concerning a child who was vaccinated with MMR (second generation). Subsequently the patient developed seizures. Unspecified medical attention was sought. Upon internal review, the convulsions as considered to be an other important medical event (OMIC). The registered nurse also reported that another child developed a seizure and lost cognitive ability. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Neurodevelopmental disorder
Clinical narrative: Information has been received from a health professional concerning a 5 year old male patient with no known drug allergies and no medical history, who was vaccinated on 07/13/1997 with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second genration)(Lot # 624669/1582E).  Subsequently, the patient developed "slight difficulty with fine motor and skilled motor skills".  He was seen by a pediatric neurologist in August 2002, and no clear cut autistic symptoms were noted.  Conflicting follow-up information received from the mother indicated the patient received measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in 1998.  The mother expressed concern about the lot number.  the records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  Additional information has been requested.
Age: 1.5
Sex: M
Vaccine: HIBV, MMR
Symptoms: Body temperature increased, Injection site erythema, Injection site mass, Injection site warmth, Urticaria
Clinical narrative: Information has been received concerning a 17 month old male patient with no known allergies, and history of chronically elevated "white count", who on 09/10/2002 at 13:00 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 641720/0351M), and a dose of Haemophilus B conjugate vaccine (manufacturer unknown).  On 09/11/2002 at 16:00 he developed an "allergic reaction (hives)" on his trunk, and had a red warm mass at the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) injection site.  It was reported that over the next 24 hours the hives spread and involved the rest of the trunk, the arms, and face.  The local injection site reaction decreased and consisted of only a "series of small bumps similar to insect bites" within 24 hours.  It was noted he had a very mild fever during this episode.  The hives cleared within 3 days (approximately 09/13/2002).  It was noted the mother has a strong allergic history.  Unspecified medical attention was sought.  Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician concerning a patient who had been vaccinated on unspecified dates with "3 or 4 doses" of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, it was reported the patient did not seroconvert.  It is unknown whether medical attention was sought.  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Infection, Rash pruritic
Clinical narrative: Information has been received from a doctor of pharmacy concerning a female (age not given) who was vaccinated on an unknown date with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 0128-invalid).  Subsequently the patient developed a unilateral pruritis that was determined to be mumps.  The patient sough unspecified medical attention.  No intervention data was provided.  Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Staring
Clinical narrative: Information has been received from a physician concerning a 15 month old female patient with allergies to amoxicillin (AMOXIL) and cefprozil (CEFZIL) who on 09/18/2002 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medication.  On 09/25/2002 the patient became limp following a "staring spell", which lasted one minute.  The physician does not know whether the event was associated with the vaccine, or whether the event was a seizure of syncope.  It was reported that no further episodes of the same occurred.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Initial and follow-up information has been received from a health professional concerning a 30 year old white female with no known drug allergies and no past medical history who on 06/17/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) subcutaneously (Lot # 639986/1213L).  On 07/18/2002 the patient was vaccinated with another dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) subcutaneously (Lot # 642181/0153M).  There was no concomitant medication.  On 09/26/2002 the patient had a serum measles immunoglobulin G antibody test that was negative.  It was reported that no adverse symptoms were noted.  The patient sought unspecified medical attention.  No additional information is expected.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician concerning a new female employee in her late 20's early 30's, who in approximately October 2002, was vaccinated with her second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  In September 2002, on an employment physical a titer was drawn which was negative for rubella.  Unspecified medical attention was sought.  The physician also reported that another new female employee who was vaccinated with the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) had a titer which was negative for measles (WAES # 02100USA00839).  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician concerning a new female employee in her late 20's to early 30's, who in approximately October 2002 was vaccinated with her second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  In September 2002, on an employment physician a titer was drawn which was negative for measles.  Unspecified medical attention was sought.  Follow up information was received from the physician who reported that the patient did not come back for follow up.  The physician reported that the patient did not provide an immunization record and was not sure if the patient had received any vaccinations in the past.  The physician also reported that another new female employee who was vaccinated with the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) had a titer which was negative for rubella (WAES # 0210USA00516).  Additional information is not expected.
Age: 40.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a registered nurse concerning a 40 year old female who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) "as a child" (Lot number not reported).  On 07/29/2002, laboratory evaluations revealed a titer for rubella was negative.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 1.9
Sex: M
Vaccine: MMR
Symptoms: Rash macular, Rash papular
Clinical narrative: Information has been received from a medical assistant concerning a 21 month old black male patient with no known drug allergies, who on 09/27/2002 was vaccinated subcutaneously in the left thigh with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 643498/0609M).  Illness at the time of vaccination included a sinus infection.  On 10/08/2002 the patient presented to the doctor's office with a diffuse maculopapular rash over his entire body.  No other symptoms were noted and no treatment was given.  Subsequently, the patient recovered.  Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Strabismus
Clinical narrative: Information has been received from a physician concerning a 4 year old male patient with no past medical history and no known drug allergies, who on 02/15/2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medication.  On 02/18/2000 the patient's "eyes were crossed".  Subsequently, the patient was seen by an eye doctor who diagnosed "Ethatropia, palsy of eye."  It was noted that the eye doctor could not be sure if the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) was the cause of the palsy, but it was probably caused by a virus.  The patient recovered in a "couple of months".  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Injection site rash
Clinical narrative: Information has been received on 10/14/2002 from a mother concerning her son with no past medical history and no known allergies who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medication.  The mother reported that her son had a "rash on arm where he was vaccinated."  The patient sought unspecified medical attention.  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Diarrhoea
Clinical narrative: Information has been received from a Doctor of Pharmacy concerning a male child with celiac sprue who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccinel ive (+) rubella virus vaccine live (second generation).  One week after vaccination, the patient developed diarrhea.  Unspecified medical attention was sought by the patient.  Additional information has been requested.
Age: 13.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a registered nurse and physician concerning a 13 year old Caucasian male with no past medical history and no know drug allergies who was vaccinated with a first and second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on 09/07/1990 and 06/10/1994 respectively.  There was no concomitant medication and no illness at the time of vaccination.  On 10/11/2002, a titer was drawin from the patient that did not show seroconversion for mumps.  On 10/11/2002 the patient's mumps IgG and IgM were <IC EIA units (not detected).  On 10/18/2002 the patient was vaccinated IM with a booster dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642440/0233M).  On 11/11/2002 the patient's mumps IgG was 12 EIA units (indeterminate) and mumps IgM was <10 EIA (not detected).  It was also reported that the patients brother was also immunized and developed mumps (WAES # 0212USA02008).  No further information is expected.
Age: 1.9
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema multiforme
Clinical narrative: Information has been received concerning a less than 2 year old female who on an unspecified date was vaccinated with a dose of MMR (second generation). Concomitant therapy, that same day, included a dose of poliovirus vaccine (IPOL) and a dose of diphtheria toxoid/pertussis vaccine/tetanus toxoid (INFANRIX). Subsequently, at an unspecified time post-vaccination, the patient developed erythema multiforme. The reporting pharmacist was not sure if the erythema multiforme was caused by diphtheria toxoid/pertussis vaccine/tetanus toxoid (INFANRIX) or MMR (second generation). As of 10/4/02, the event was worse. Erythema multiforme was considered medically serious (OMIC). Therefore erythema multiforme was considered to be an other important medical event. This was originally reported by a pharmacist. Upon follow up, the pharmacist reported that the information was reported from on of the clinic sites. No additional information was received. This is a consolidation of two reports containing the same patient. Additional information is not expected.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning an approximately 27 year old female patient with a history of polycystic ovary syndrome, who in 1977 was vaccinated with a dose of "a measles vaccine" (manufacturer unknown) and in 1993 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Concomitant therapy included metformin.  On 10/28/2002 it was reported that "recently dose serology testing showed that she is not immune to the measles".  Unspecified medical attention was sought, but no intervention was done.  Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Paraesthesia
Clinical narrative: Information has been received from a physician concerning a 35 year old female with latex allergy who on 10/28/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (Lot # 642182/0774M).  On 10/28/2002 the patient experienced right arm tingling which shortly thereafter moved to the right side of her face.  As of 10/28/2002, the physician reported that the patient's experiences had abated.  The patient sought unspecified medical attention.  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Nonspecific reaction
Clinical narrative: Information has been received from a physician via a pharmacist concerning a female adult who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, the patient experienced an unspecified "alleged reaction."  Unspecified medical attention was sought.  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Nonspecific reaction
Clinical narrative: Information has been received from a consumer via her mother, a nurse, that a male child was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  The next day, the child was "different".  It was unknown whether the child sought medical attention.  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Dyspnoea
Clinical narrative: Information has been received from a pharmacist concerning her sister-in-law, a female with asthma who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, the patient experienced difficulty in breathing.  The patient sought unspecified medical attention.  No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a consumer concerning her son with no known allergies and no prior medical history who in 1997 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medication.  Subsequently, on an unspecified date, the patient showed an immunity to the mumps and to rubella but not to the measles.  Subsequently, the patient was revaccinated.  The patient sought unspecified medical attention.  Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Agitation, Constipation, Fatigue, Lethargy, Malaise
Clinical narrative: Information has been received from a consumer concerning a 14 month old male pt with down's syndrome, who on 10/14/02 was vaccinated with a dose of MMR II. Concomitant vaccination included a dose of varicella virus vaccine live. On approximately 10/21/02 the pt developed constipation for over one week, was "crabby and crying," developed a rash, had a temperature of 102 and experienced fatigue, lethargy and malaise. These adverse events were described as "reactions from MMR II or varicella virus vaccine live." Unspecified medical attention was sought. The pt previously had adverse events post vaccination with hep B vaccine (WAES0211USA00367). Additional info has been requested.
Age: 1.2
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning a 14 month old male pt with down's syndrome, who on 10/14/02 was vaccinated with a dose of MMR II. Concomitant vaccination included a dose of varicella virus vaccine live. On approximately 10/21/02 the pt developed constipation for over one week, was "crabby and crying," developed a rash, had a temperature of 102 and experienced fatigue, lethargy and malaise. These adverse events were described as "reactions from MMR II or varicella virus vaccine live." Unspecified medical attention was sought. The pt previously had adverse events post vaccination with hep B vaccine (WAES0211USA00367). Additional info has been requested.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash papular
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old female with no  known allergies, birth defects or pre-existing medical conditions who on 10/22/02 was vaccinated with a dose of MMR II given SC in the left leg (641881/0772M). On 10/31/02 (previously reported as approximately 10/22/02) the pt developed a scattered papular rash on her abdomen and a high temperature. On 11/1/02 the pt was seen in her physician's office. The pt was treated with Advil and her fever responded to it. Hospitalization was not required. Subsequently, the pt recovered. The pt sought unspecified medical attention. No further info is available.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Cough, Nasal congestion, Pyrexia, Rash maculo-papular, Rhinorrhoea
Clinical narrative: Information has been received from a physician's assistant concerning a 12 month old female with no known allergies and no prior medical history who on 10/21/02 at 10:00 was vaccinated with a dose of MMR II (640156/0978L). Concomitant therapy included a dose of varicella virus vaccine live administered in the right leg (638165/0158L). There was no illness at the time of vaccination. On 11/3/02, the pt presented to a physician's office with a maculopapular rash from head to toe (previously reported as "rash covered on face, extremities, and trunk"), low grade fever, runny nose, congestion and cough. In 2002, the pt had Rubeola IgM/IgG testing (results not reported). Subsequently in 2002, the pt recovered. The pt sought unspecified medical attention. Additional info is not expected.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old female who on 2/4/00 was vaccinated with a first dose of MMR II (632532/1270J). On 2/4/00, the pt was concomitantly vaccinated with a first dose of Haemophilus influenzae vaccine.  On 2/14/00, the pt developed a fever and rash. Medical attention was sought, and the pt was treated with Tylenol. Additional info has been requested.
Age: 1.2
Sex: M
Vaccine: MMR
Symptoms: Skin irritation
Clinical narrative: Information has been received from a mother concerning her 14 month old son with no known drug allergies and no past medical history who was vaccinated with a dose of MMR II. There was no concomitant medication. Subsequently the pt's stool irritated his skin. The mother felt that the stool irritation was related to the ingredients of the MMR II which was excreted in his stool and irritated his skin. The pt sought unspecified medical attention. Additional info is not expected.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Face oedema, Viral infection
Clinical narrative: Information has been received from a physician concerning a 15 month old female pt with no past medical history who on 10/16/02 was vaccinated with a first dose of MMR II (641882/0531M), in the right leg. There was no illness at the time of vaccination. On 11/5/02 the pt developed unilateral mumps and swollen right and left face. Unspecified medical attention was sought. Follow-up noted that there was no redness or tenderness. It was also reported that the pt recovered. No further info is expected.
Age: 9.0
Sex: M
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a doctor of chiropractic medicine concerning his 9 year old son with a "minor issue with attention deficit" who "several years ago" was vaccinated with a dose of MMR II. On approximately 11/6/02, the pt developed high levels of lead and arsenic which was found in a hair analysis. The doctor of chiropractic medicine indicated that he was not stating that MMR II was the cause, but was told that childhood vaccines could produce "this type of results." The pt sought unspecified medical attention. Additional info has been requested.
Sex: F
Vaccine: MMR
Symptoms: Eczema, Injection site erythema, Injection site induration, Rash
Clinical narrative: Information has been received from a nurse practitioner concerning a female who was vaccinated with a dose of MMR II. Subsequently, the pt immediately developed redness and induration at the injection site. "About two weeks later," the pt developed a rash over her entire body "that turned into eczema." The pt sought unspecified medical attention. The nurse practitioner felt that the pt's redness and induration at the injection site, rash and eczema "was a reaction to the neomycin." Additional info has been requested.
Age: 2.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Convulsion, Pyrexia, Staring
Clinical narrative: Information has been received from a consumer's mother concerning her 2 year old daughter with no prior medical history and no known allergies who in February 2000, was vaccinated with a dose of MMR (second generation). Concomitant vaccination included a dose of diphtheria toxoid/pertussis vaccine/tetanus and a dose of poliovirus vaccine, as well as two other normal childhood vaccines. Following vaccination, the patient developed a fever of 102F and had a staring seizure. Unspecified medical attention was sought. Upon internal review, staring seizure was determined to be an other important medical event (OMIC). Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: MMR
Symptoms: Drug administration error, Eye disorder
Clinical narrative: Initial and follow-up info has been received from a health professional concerning a 34 year old female nurse with hypothyroidism who on 11/7/02 was vaccinating a pt with MMR II. It was reported that while the nurse was administering the vaccine to a child some accidentally splashed in her eyes due to a faulty needle device (safety syringe). The nurses eye was flushed for 5 minutes after the incident. The nurse was seen the next day on 11/8/02, in occupational health. Her eye was examined by occupational health and was diagnosed with an abrasion. She was treated with unspecified eye drops. A HIV test and hepatitis panel were all negative. Subsequently, the pt recovered from the eye abrasion. No further info is expected.
Sex: M
Vaccine: MMR
Symptoms: Rash morbilliform
Clinical narrative: Information has been received from a physician concerning a male infant who was breast fed by his mother, who had been vaccinated with a dose of MMR II on 10/25/02. Subsequently on an unspecified date after breast feeding, the infant "broke out with a measles like rash." The reporter indicated he was told by the father that the vaccine the mother received was MMR II. The reporter indicated he thinks the hospital only stocks rubella virus vaccine live. It was noted the infant did not have a fever and was not ill, but was covered with the rash for 2 days. The rash was fading at the time of this report. Unspecified medical attention was sought. Additional info has been requested.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Disorientation, Dysphonia, Fatigue, Headache
Clinical narrative: Information has been received from a health professional concerning an approximately 21 year old female pt who in approximately 1990 was vaccinated with a third dose of MMR II. Subsequently, the pt developed swollen glands and a fever and later recovered. On 10/29/02 at 3:00pm, the pt was vaccinated SC in the left arm with a fourth dose of MMR II (642539/0631M). At that time the pt was a 34 year old with depression and allergies to penicillin, Keflex, Cipro, Biaxin, erythromycin and Zithromax. There was no illness at the time of vaccination. On 10/29/02 approximately a half hour after vaccination, the pt developed a severe headache that lasted until the morning of 10/31/02. On 10/29/02 the pt also developed a fever of 99.7 F, fatigue, joint pain "in all of body" described as "achy" and she "felt like had the flu." On 10/29/02 at 7pm, the pt developed a "horse voice," glands in her throat became swollen and she became "disoriented for 24 hrs." On 10/31/02 the pt recovered. Additional info is not expected.
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: Information has been received from a health professional concerning an approximately 21 year old female pt who in approximately 1990 was vaccinated with a third dose of MMR II. Subsequently, the pt developed swollen glands and a fever and later recovered. On 10/29/02 at 3:00pm, the pt was vaccinated SC in the left arm with a fourth dose of MMR II (642539/0631M). At that time the pt was a 34 year old with depression and allergies to penicillin, Keflex, Cipro, Biaxin, erythromycin and Zithromax. There was no illness at the time of vaccination. On 10/29/02 approximately a half hour after vaccination, the pt developed a severe headache that lasted until the morning of 10/31/02. On 10/29/02 the pt also developed a fever of 99.7 F, fatigue, joint pain "in all of body" described as "achy" and she "felt like had the flu." On 10/29/02 at 7pm, the pt developed a "horse voice," glands in her throat became swollen and she became "disoriented for 24 hrs." On 10/31/02 the pt recovered. Additional info is not expected.
Age: 41.0
Sex: F
Vaccine: MMR
Symptoms: Drug administration error, Dry eye
Clinical narrative: Information has been received from a 41 year old female registered nurse with asthma, Fuch's dystrophy, and allergy to penicillin, tetracycline and bee stings. On 11/18/02, the nurse had administered a dose of MMR II, with a retractable syringe. It was reported that "the needle pulled out of the syringe and aerosolized into her left eye. She was wearing glasses but it enetered over the top of them. The nurse flushed her eye with tap water. She now has a sensation of dryness in her eye." It was noted that concomitant therapy included Flovent and albuterol. The pt sought unspecified medical treatment. Additional info has been requested.
Age: 11.0
Sex: F
Vaccine: DT, HEP, MMR
Symptoms: Headache, Myalgia
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old female with no known allergies and no past medical history who in the AM of 11/20/02 was vaccinated SQ with the third dose of MMR II (639692/0635M). Concomitant vaccinations that day in the AM included a third dose of hep B vaccine recombinant (642741/0153M) given IM and sixth dose of Td (V0527AA) given IM. Concomitant medications on 9/3/02 included a first dose of MMR II. Concomitant medications on 11/19/02 included a second dose of MMR II (639692/0635M) given SQ and a second dose of hep B vaccine (642741/0153M) given IM. There was no illness at the time of vaccination. Subsequently, on 11/20/02 at 11AM the pt experienced a headache and arm soreness. Unspecified medical attention was sought. The reporter indicated that the pt recovered on 11/20/02. No diagnostic tests or lab data was reported. No further info is expected.
Age: 13.0
Sex: M
Vaccine: HEP, MMR
Symptoms: Headache, Myalgia
Clinical narrative: Information has been received from a registered nurse concerning a 13 year old male pt with no known drug allergies and no past medical history who in the AM of 11/20/02 was vaccinated SQ with the third doses of MMR II (639692/0635M). Concomitant medications that day in the AM included the third dose of hep B vaccine recombinant (641741/0153M) given IM. Concomitant medication on 11/19/02 in the AM included the second dose of MR II (639692/0635M) given SQ and the second dose of hep B vaccine recombinant (641741/0153M) given IM. There was no illness at the time of vaccination. Subsequently, on 11/20/02 at 10am, the pt experienced a headache and arm soreness. Unspecified medical attention was sought. The reporter indicated that on 11/20/02, the pt recovered. No diagnostic tests or lab data were reported. No further info is expected.
Sex: F
Vaccine: MMR
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: Information has been received from a nurse practitioner concerning a female who was vaccinated with MMR II. Subsequently the pt developed enlarged lymph nodes and myalgia without fever. After a few days the pt recovered. The pt sought unspecified medical attention. Additional info has been requested.
Age: 1.25
Sex: F
Vaccine: MMR
Symptoms: Convulsion
Clinical narrative: Information has been received from a consumer concerning a 15 month old female, with no relevant medical history, who in June 1991, was vaccinated with a dose of MMR (second generation), (no lot number reported). There was no concomitant medication. In June 1991, two days post-vaccination the patient had a seizure. The patient went to the physician's office and unspecified medical attention was sought. Upon internal review, the patient's seizure was considered an other medical event (OMIC). No additional information is expected.
Age: 1.4
Sex: F
Vaccine: DTAPH, MMR, PNC
Symptoms: Corneal disorder, Erythema, Eye oedema, Rash macular, Screaming
Clinical narrative: Information has been received from a pharmacist who was the mother of a 17 month old female pt with no known pre-existing allergies, birth defects or medical conditions who on 11/26/02 at 11am was vaccinated in the left arm with a first dose of MMR II (641881/0772M). There was no illness at the time of vaccination. On 11/26/02 at 11am, the pt was concomitantly vaccinated in the right thigh with with a fourth dose of Prevnar (485989) and a fourth dose of Tirhibit (VA739AA 40555CB) in the left thigh. The pt developed swelling of her eyes and "crying for six hours." The pt was observed for three hours at the pediatrician's office and was then referred to an opthalmologist at the hospital. The pt was treated with IM Benadryl. Additional info received from the physician indicated that on 11/26/02 within minutes after the vaccine was administered the pt screamed, held eye and wouldn't open eyes, "particularly the pt did not want to keep eyes open and was holding right eye more than the left." The area around the right eye was slightly erythematous and swollen. There was blotchy skin on the forehead with crying. Everything noted with the erythema and swelling resolved when the pt stopped crying; however, the pt would not keep her eye open. The pt was sent to an eye doctor and it was noted that she had a right corneal abrasion. It was noted that the pt recovered on 11/28/02 and that the "condition likely not related to vaccine." No further info is expected. This is a consolidation of two reports concerning the same pt.
Sex: F
Vaccine: MMR
Symptoms: Chills, Erythema multiforme, Pyrexia, Serum sickness
Clinical narrative: Information has been received from a physician concerning her college-aged daughter who in approximately 1983 was vaccinated with a dose of MMR II. It was reported that the pt developed serum sickness, as well as erythema multiforme which became confluent. Additionally, the pt experienced rigors and a fever up to 105 degrees. The report did not indicate that the child had been hospitalized or that the AEs met any other serious criteria. It was noted that the child had "a lot of allergies." The pt has since recovered and is currently attending college. No other info was reported. Additional info has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning an adult female patient with a penicillin allergy who in 1995 or 1996 was vaccinated with a third dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  The reporter indicated that the patient received a first and second dose at 15 months and 11 years of age respectively.  A titer was drawn and was negative at 0.85.  Unspecified medical attention was sought.  No further information is available.
Age: 1.25
Sex: M
Vaccine: HBHEPB, MMR
Symptoms: Irritability, Pyrexia, Rash, Upper respiratory tract infection
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old Caucasian male patient with an acute ear infection and positive green rhinorrhea, who on 11/19/02 was vaccinated SC into the right thigh with a dose of MMR (second generation) (lot #642182/0774M). Concomitant vaccination included a dose of Haemophilus B conjugate vaccine (+) hepatitis B vaccine recombinant (lot # 643305/0692M). Concomitant therapy included amoxiclllin for the treatment of the patient's acute ear infection and positive green rhinorrhea. On 11/27/02 the patient developed a localized, pinpoint rash that the physician documented as a measles-like rash and a temperature of 103 degrees F. The rash was described as a possible antibiotic reaction or a possible reaction to the MMR (second generation). The reporter indicated that there were no other symptoms and that the patient was eating and drinking. The patient was cranky and the rash worsened over the next several days spreading all over the trunk, face, hair and mouth. On 11/30/02 the patient returned to the doctors office. It was also reported that the patient had developed an upper respiratory infection. It was reported that the patient was negative for roseola and Kawasaki. The reporter indicates that the patient's experience resulted in persistent or significant incapacity. It was reported that the patient recovered from this experiences. Additional information is not expected.